Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO Subscriptions PDA Services My JCO Customer Service

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scheuer, L.
Right arrow Articles by Offit, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scheuer, L.
Right arrow Articles by Offit, K.
Journal of Clinical Oncology, Vol 20, Issue 5 (March), 2002: 1260-1268
© 2002 American Society for Clinical Oncology

Outcome of Preventive Surgery and Screening for Breast and Ovarian Cancer in BRCA Mutation Carriers

By Lauren Scheuer, Noah Kauff, Mark Robson, Bridget Kelly, Richard Barakat, Jaya Satagopan, Nathan Ellis, Martee Hensley, Jeff Boyd, Patrick Borgen, Larry Norton, Kenneth Offit

From the Clinical Genetics, Breast Cancer Medicine, and Developmental Chemotherapy Services, Department of Medicine; Breast and Gynecology Services, Department of Surgery; and Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY.

Address reprint requests to Kenneth Offit, MD, MPH, Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021; email: offitk{at}mskcc.org

PURPOSE: To prospectively determine the impact of genetic counseling and testing on risk-reduction strategies and cancer incidence in a cohort of individuals at hereditary risk for breast and ovarian cancer.

PATIENTS AND METHODS: Two hundred fifty-one individuals with BRCA mutations were identified at a single comprehensive cancer center from May 1, 1995, through October 31, 2000. Uniform recommendations regarding screening and preventive surgery were provided in the context of genetic counseling. Patients were followed for a mean of 24.8 months (range, 1.6 to 66.0 months) using standardized questionnaires, chart reviews, and contact with primary physicians.

RESULTS: Frequency of cancer surveillance by physical examinations and imaging studies increased after genetic counseling and testing. Twenty-one breast, ovarian, primary peritoneal, or fallopian tube cancers were detected after receipt of genetic test results. Among 29 individuals choosing risk-reducing mastectomy after testing, two were found to have occult intraductal breast cancers. Among 90 individuals who underwent risk-reducing salpingo-oophorectomy, one early-stage ovarian neoplasm and one early-stage fallopian tube neoplasm were found. Radiographic or tumor marker–based screening detected six breast cancers, five of which were stage 0/I, one early-stage primary peritoneal cancer, and three stage I or II ovarian cancers. Six additional breast cancers were detected by physical examination between radiographic screening intervals; four of these six tumors were stage I. No stage III or stage IV malignancies were detected after genetic testing.

CONCLUSION: This study provides prospective evidence that genetic counseling and testing increased surveillance and led to risk-reducing operations, which resulted in diagnosis of early-stage tumors in patients with BRCA1 and BRCA2 mutations.




This article has been cited by other articles:


Home page
 ANN INTERN MEDHome page
E. Warner, H. Messersmith, P. Causer, A. Eisen, R. Shumak, and D. Plewes
Systematic Review: Using Magnetic Resonance Imaging to Screen Women at High Risk for Breast Cancer
Ann Intern Med, May 6, 2008; 148(9): 671 - 679.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
M. T. Scheuner, P. Sieverding, and P. G. Shekelle
Delivery of Genomic Medicine for Common Chronic Adult Diseases: A Systematic Review
JAMA, March 19, 2008; 299(11): 1320 - 1334.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
N. D. Kauff, S. M. Domchek, T. M. Friebel, M. E. Robson, J. Lee, J. E. Garber, C. Isaacs, D. G. Evans, H. Lynch, R. A. Eeles, et al.
Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study
J. Clin. Oncol., March 10, 2008; 26(8): 1331 - 1337.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
R. Z. Bigenwald, E. Warner, A. Gunasekara, K. A. Hill, P. A. Causer, S. J. Messner, A. Eisen, D. B. Plewes, S. A. Narod, L. Zhang, et al.
Is Mammography Adequate for Screening Women with Inherited BRCA Mutations and Low Breast Density?
Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 706 - 711.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
J. M. Lee, D. B. Kopans, P. M. McMahon, E. F. Halpern, P. D. Ryan, M. C. Weinstein, and G. S. Gazelle
Breast Cancer Screening in BRCA1 Mutation Carriers: Effectiveness of MR Imaging--Markov Monte Carlo Decision Analysis
Radiology, March 1, 2008; 246(3): 763 - 771.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Radiol.Home page
M J BERMEJO-PEREZ, S MARQUEZ-CALDERON, and A LLANOS-MENDEZ
Cancer surveillance based on imaging techniques in carriers of BRCA1/2 gene mutations: a systematic review
Br. J. Radiol., March 1, 2008; 81(963): 172 - 179.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
A. Wijayanayagam, A. S. Kumar, R. D. Foster, and L. J. Esserman
Optimizing the Total Skin-Sparing Mastectomy
Arch Surg, January 1, 2008; 143(1): 38 - 45.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
P. A. Causer, R. A. Jong, E. Warner, K. Hill, J. W. Wong, B. N. Curpen, and D. B. Plewes
Breast Cancers Detected with Imaging Screening in the BRCA Population: Emphasis on MR Imaging with Histopathologic Correlation
RadioGraphics, October 1, 2007; 27(suppl_1): S165 - S182.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. N. Weitzel, V. I. Lagos, J. S. Herzog, T. Judkins, B. Hendrickson, J. S. Ho, C. N. Ricker, K. J. Lowstuter, K. R. Blazer, G. Tomlinson, et al.
Evidence for Common Ancestral Origin of a Recurring BRCA1 Genomic Rearrangement Identified in High-Risk Hispanic Families
Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1615 - 1620.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. L. Smith, M. Adank, N. Kauff, K. Lafaro, J. Boyd, J. B. Lee, C. Hudis, K. Offit, and M. Robson
BRCA Mutations in Women with Ductal Carcinoma In situ
Clin. Cancer Res., July 15, 2007; 13(14): 4306 - 4310.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
M. Robson and K. Offit
Management of an Inherited Predisposition to Breast Cancer
N. Engl. J. Med., July 12, 2007; 357(2): 154 - 162.
[Full Text] [PDF]

Home page
 JCOHome page
N. D. Kauff and R. R. Barakat
Risk-Reducing Salpingo-Oophorectomy in Patients With Germline Mutations in BRCA1 or BRCA2
J. Clin. Oncol., July 10, 2007; 25(20): 2921 - 2927.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
E. S. Hwang, J. L. McLennan, D. H. Moore, B. B. Crawford, L. J. Esserman, and J. L. Ziegler
Ductal Carcinoma In Situ in BRCA Mutation Carriers
J. Clin. Oncol., February 20, 2007; 25(6): 642 - 647.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
J. V. Lacey Jr, M. H. Greene, S. S. Buys, D. Reding, T. L. Riley, C. D. Berg, R. M. Fagerstrom, and P. Hartge
Ovarian Cancer Screening in Women With a Family History of Breast or Ovarian Cancer.
Obstet. Gynecol., November 1, 2006; 108(5): 1176 - 1184.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
K. M. Schmeler, C. C. Sun, D. C. Bodurka, K. G. White, P. T. Soliman, A. R. Uyei, J. L. Erlichman, B. K. Arun, M. S. Daniels, S. A. Rimes, et al.
Prophylactic Bilateral Salpingo-Oophorectomy Compared With Surveillance in Women With BRCA Mutations.
Obstet. Gynecol., September 1, 2006; 108(3): 515 - 520.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. Bradbury and O. I. Olopade
The Case for Individualized Screening Recommendations for Breast Cancer
J. Clin. Oncol., July 20, 2006; 24(21): 3328 - 3330.
[Full Text] [PDF]

Home page
 JAMAHome page
T. Walsh, S. Casadei, K. H. Coats, E. Swisher, S. M. Stray, J. Higgins, K. C. Roach, J. Mandell, M. K. Lee, S. Ciernikova, et al.
Spectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast Cancer
JAMA, March 22, 2006; 295(12): 1379 - 1388.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
K. Anderson, J. S. Jacobson, D. F. Heitjan, J. G. Zivin, D. Hershman, A. I. Neugut, and V. R. Grann
Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation.
Ann Intern Med, March 21, 2006; 144(6): 397 - 406.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. Chen, E. S. Iversen, T. Friebel, D. Finkelstein, B. L. Weber, A. Eisen, L. E. Peterson, J. M. Schildkraut, C. Isaacs, B. N. Peshkin, et al.
Characterization of BRCA1 and BRCA2 Mutations in a Large United States Sample
J. Clin. Oncol., February 20, 2006; 24(6): 863 - 871.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. L. Kramer, I. A. Velazquez, B. E. Chen, P. S. Rosenberg, J. P. Struewing, and M. H. Greene
Prophylactic Oophorectomy Reduces Breast Cancer Penetrance During Prospective, Long-Term Follow-Up of BRCA1 Mutation Carriers
J. Clin. Oncol., December 1, 2005; 23(34): 8629 - 8635.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. K. Kuhl, S. Schrading, C. C. Leutner, N. Morakkabati-Spitz, E. Wardelmann, R. Fimmers, W. Kuhn, and H. H. Schild
Mammography, Breast Ultrasound, and Magnetic Resonance Imaging for Surveillance of Women at High Familial Risk for Breast Cancer
J. Clin. Oncol., November 20, 2005; 23(33): 8469 - 8476.
[Abstract] [Full Text] [PDF]

Home page
 Health Educ BehavHome page
S. M. Miller, P. Roussi, M. B. Daly, J. S. Buzaglo, K. Sherman, A. K. Godwin, A. Balshem, and M. E. Atchison
Enhanced Counseling for Women Undergoing BRCA1/2 Testing: Impact on Subsequent Decision Making About Risk Reduction Behaviors
Health Educ Behav, October 1, 2005; 32(5): 654 - 667.
[Abstract] [PDF]

Home page
 ANN INTERN MEDHome page
H. D. Nelson, L. H. Huffman, R. Fu, and E. L. Harris
Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review for the U.S. Preventive Services Task Force
Ann Intern Med, September 6, 2005; 143(5): 362 - 379.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
I. Jacobs
Screening for Familial Ovarian Cancer: The Need for Well-Designed Prospective Studies
J. Clin. Oncol., August 20, 2005; 23(24): 5443 - 5445.
[Full Text] [PDF]

Home page
 JCOHome page
D. Stirling, D. G. R. Evans, G. Pichert, A. Shenton, E. N. Kirk, S. Rimmer, C. M. Steel, S. Lawson, R.M. C. Busby-Earle, J. Walker, et al.
Screening for Familial Ovarian Cancer: Failure of Current Protocols to Detect Ovarian Cancer at an Early Stage According to the International Federation of Gynecology and Obstetrics System
J. Clin. Oncol., August 20, 2005; 23(24): 5588 - 5596.
[Abstract] [Full Text] [PDF]

Home page
 JRSMHome page
M. Steel
Molecular medicine: promises, promises?
J R Soc Med, May 1, 2005; 98(5): 197 - 199.
[Full Text] [PDF]

Home page
 CarcinogenesisHome page
A.-M. Simeone, C.-X. Deng, G. J. Kelloff, V. E. Steele, M. M. Johnson, and A. M. Tari
N-(4-Hydroxyphenyl)retinamide is more potent than other phenylretinamides in inhibiting the growth of BRCA1-mutated breast cancer cells
Carcinogenesis, May 1, 2005; 26(5): 1000 - 1007.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. A. Narod and K. Offit
Prevention and Management of Hereditary Breast Cancer
J. Clin. Oncol., March 10, 2005; 23(8): 1656 - 1663.
[Full Text] [PDF]

Home page
 JCOHome page
C. B. Powell, E. Kenley, L.-m. Chen, B. Crawford, J. McLennan, C. Zaloudek, M. Komaromy, M. Beattie, and J. Ziegler
Risk-Reducing Salpingo-Oophorectomy in BRCA Mutation Carriers: Role of Serial Sectioning in the Detection of Occult Malignancy
J. Clin. Oncol., January 1, 2005; 23(1): 127 - 132.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
K. Offit, E. Groeger, S. Turner, E. A. Wadsworth, and M. A. Weiser
The "Duty to Warn" a Patient's Family Members About Hereditary Disease Risks
JAMA, September 22, 2004; 292(12): 1469 - 1473.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
E. Warner, D. B. Plewes, K. A. Hill, P. A. Causer, J. T. Zubovits, R. A. Jong, M. R. Cutrara, G. DeBoer, M. J. Yaffe, S. J. Messner, et al.
Surveillance of BRCA1 and BRCA2 Mutation Carriers With Magnetic Resonance Imaging, Ultrasound, Mammography, and Clinical Breast Examination
JAMA, September 15, 2004; 292(11): 1317 - 1325.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
M. E. Robson and K. Offit
Breast MRI for Women With Hereditary Cancer Risk
JAMA, September 15, 2004; 292(11): 1368 - 1370.
[Full Text] [PDF]

Home page
 NEJMHome page
M. Kriege, C. T.M. Brekelmans, C. Boetes, P. E. Besnard, H. M. Zonderland, I. M. Obdeijn, R. A. Manoliu, T. Kok, H. Peterse, M. M.A. Tilanus-Linthorst, et al.
Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition
N. Engl. J. Med., July 29, 2004; 351(5): 427 - 437.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
L. Liberman
Breast Cancer Screening with MRI -- What Are the Data for Patients at High Risk?
N. Engl. J. Med., July 29, 2004; 351(5): 497 - 500.
[Full Text] [PDF]

Home page
 J. Med. Genet.Home page
K R Blazer, M Grant, S R Sand, D J MacDonald, G C Uman, and J N Weitzel
Effects of a cancer genetics education programme on clinician knowledge and practice
J. Med. Genet., July 1, 2004; 41(7): 518 - 522.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. Hogg and M. Friedlander
Biology of Epithelial Ovarian Cancer: Implications for Screening Women at High Genetic Risk
J. Clin. Oncol., April 1, 2004; 22(7): 1315 - 1327.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
I. J. Jacobs and U. Menon
Progress and Challenges in Screening for Early Detection of Ovarian Cancer
Mol. Cell. Proteomics, April 1, 2004; 3(4): 355 - 366.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. W. Hadley, J. F. Jenkins, E. Dimond, M. de Carvalho, I. Kirsch, and C. G.S. Palmer
Colon Cancer Screening Practices After Genetic Counseling and Testing for Hereditary Nonpolyposis Colorectal Cancer
J. Clin. Oncol., January 1, 2004; 22(1): 39 - 44.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
B. N. Peshkin, C. Isaacs, C. Finch, S. Kent, and M. D. Schwartz
Tamoxifen As Chemoprevention in BRCA1 and BRCA2 Mutation Carriers With Breast Cancer: A Pilot Survey of Physicians
J. Clin. Oncol., December 1, 2003; 21(23): 4322 - 4328.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
J. N. Weitzel, S. M. McCaffrey, R. Nedelcu, D. J. MacDonald, K. R. Blazer, and C. A. Cullinane
Effect of Genetic Cancer Risk Assessment on Surgical Decisions at Breast Cancer Diagnosis
Arch Surg, December 1, 2003; 138(12): 1323 - 1328.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
K. D. McKelvey Jr. and J. P. Evans
Cancer Genetics in Primary Care
J. Nutr., November 1, 2003; 133(11): 3767S - 3772.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
M.-C. King, J. H. Marks, and J. B. Mandell
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
Science, October 24, 2003; 302(5645): 643 - 646.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
B. A. Mincey
Genetics and the Management of Women at High Risk for Breast Cancer
Oncologist, October 1, 2003; 8(5): 466 - 473.
[Abstract] [Full Text] [PDF]

Home page
 CA Cancer J ClinHome page
R. A. Smith, D. Saslow, K. Andrews Sawyer, W. Burke, M. E. Costanza, W. P. Evans III, R. S. Foster Jr., E. Hendrick, H. J. Eyre, and S. Sener
American Cancer Society Guidelines for Breast Cancer Screening: Update 2003
CA Cancer J Clin, May 1, 2003; 53(3): 141 - 169.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. M. Domchek, A. Eisen, K. Calzone, J. Stopfer, A. Blackwood, and B. L. Weber
Application of Breast Cancer Risk Prediction Models in Clinical Practice
J. Clin. Oncol., February 15, 2003; 21(4): 593 - 601.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
H. T. Lynch, C. L. Snyder, J. F. Lynch, B. D. Riley, and W. S. Rubinstein
Hereditary Breast-Ovarian Cancer at the Bedside: Role of the Medical Oncologist
J. Clin. Oncol., February 15, 2003; 21(4): 740 - 753.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. M. Satagopan, J. Boyd, N. D. Kauff, M. Robson, L. Scheuer, S. Narod, and K. Offit
Ovarian Cancer Risk in Ashkenazi Jewish Carriers of BRCA1 and BRCA2 Mutations
Clin. Cancer Res., December 1, 2002; 8(12): 3776 - 3781.
[Abstract] [Full Text] [PDF]

Home page
 The ANNALS of the American Academy of Political and Social ScienceHome page
D. L. DAVIS and P. S. WEBSTER
The Social Context of Science: Cancer and the Environment
The ANNALS of the American Academy of Political and Social Science, November 1, 2002; 584(1): 13 - 34.
[Abstract] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
B. N. Peshkin, M. D. Schwartz, C. Isaacs, C. Hughes, D. Main, and C. Lerman
Utilization of Breast Cancer Screening in a Clinically Based Sample of Women after BRCA1/2 Testing
Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1115 - 1118.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. Cremin, N. Wong, K. Buzaglo, A.-J. Paradis, W. Foulkes, D.A. Berry, G. Parmigiani, W. Rubinstein, and P. Watson
Nonovarian Pelvic Cancers in BRCA1/2 Mutation Carriers and the BRCAPRO Statistical Model
J. Clin. Oncol., September 15, 2002; 20(18): 3936 - 3937.
[Full Text] [PDF]

Home page
 JCOHome page
M. G. Daidone, S. Veneroni, V. Cappelletti, P. Radice, M. A. Pierotti, M. Younes, L. Scheuer, N. D. Kauff, M. E. Robson, and K. Offit
Estrogen Receptor-Beta Expression in Hereditary Breast Cancer
J. Clin. Oncol., September 1, 2002; 20(17): 3752 - 3753.
[Full Text] [PDF]

Home page
 CA Cancer J ClinHome page
M. N. Barnes, W. E. Grizzle, C. J. Grubbs, and E. E. Partridge
Paradigms for Primary Prevention of Ovarian Carcinoma
CA Cancer J Clin, July 1, 2002; 52(4): 216 - 225.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
N. D. Kauff, J. M. Satagopan, M. E. Robson, L. Scheuer, M. Hensley, C. A. Hudis, N. A. Ellis, J. Boyd, P. I. Borgen, R. R. Barakat, et al.
Risk-Reducing Salpingo-oophorectomy in Women with a BRCA1 or BRCA2 Mutation
N. Engl. J. Med., May 23, 2002; 346(21): 1609 - 1615.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. DeMichele and B. L. Weber
Risk Management in BRCA1 and BRCA2 Mutation Carriers: Lessons Learned, Challenges Posed
J. Clin. Oncol., March 1, 2002; 20(5): 1164 - 1166.
[Full Text] [PDF]


About
JCO		 Editorial
Roster		 Advertising
Information		 Librarians &
Institutions		 Rights &
Permissions		 Site Map

Copyright © 2002 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online